Isolated peptides which bind to HLA-C molecules and uses thereof

Details for Australian Patent Application No. 2001293051 (hide)

Owner Ludwig Institute for Cancer Research Cornell Research Foundation, Inc. Memorial Sloan-Kettering Cancer Center

Inventors Nagata, Yasuhiro; Chen, Yao-Tseng; Gnjatic, Sacha; Jager, Elke; Knuth, Alexander; Old, Lloyd J.

Agent Griffith Hack

Pub. Number AU-B-2001293051

PCT Pub. Number WO02/26778

Priority 09/670,456 26.09.00 US

Filing date 24 September 2001

Wipo publication date 8 April 2002

Acceptance publication date 26 April 2007

International Classifications

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 15/47 (2006.01) Mutation or genetic engineering

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

30 September 2004 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from Ludwig Institute for Cancer Research to Ludwig Institute for Cancer Research, Cornell Research Foundation, Inc. and Memorial Sloan-Kettering Cancer Center. 2002

26 April 2007 Application Accepted

  Published as AU-B-2001293051

23 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001293052

2001293050